Business Description
Pangen Biotech Inc
ISIN : KR7222110009
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.06 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | -1.75 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.4 | |||||
Beneish M-Score | -1.69 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.1 | |||||
3-Year EBITDA Growth Rate | -10.1 | |||||
3-Year EPS without NRI Growth Rate | 2.9 | |||||
3-Year FCF Growth Rate | 13.3 | |||||
3-Year Book Growth Rate | -7.2 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 72.75 | |||||
9-Day RSI | 63.42 | |||||
14-Day RSI | 57.49 | |||||
6-1 Month Momentum % | 11.96 | |||||
12-1 Month Momentum % | 11.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.66 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 0.83 | |||||
Days Inventory | 332.87 | |||||
Days Sales Outstanding | 58.46 | |||||
Days Payable | 12.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.5 | |||||
Shareholder Yield % | -1.7 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.01 | |||||
Operating Margin % | -27.9 | |||||
Net Margin % | -31.12 | |||||
FCF Margin % | -25.75 | |||||
ROE % | -20.66 | |||||
ROA % | -14.14 | |||||
ROIC % | -13.92 | |||||
ROC (Joel Greenblatt) % | -23.01 | |||||
ROCE % | -15.83 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.48 | |||||
PB Ratio | 4.12 | |||||
Price-to-Tangible-Book | 5.41 | |||||
EV-to-EBIT | -23.85 | |||||
EV-to-EBITDA | -55.2 | |||||
EV-to-Revenue | 6.59 | |||||
EV-to-FCF | -23.29 | |||||
Price-to-Net-Current-Asset-Value | 11.17 | |||||
Earnings Yield (Greenblatt) % | -4.2 | |||||
FCF Yield % | -3.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pangen Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 10,056.766 | ||
EPS (TTM) (â‚©) | -293 | ||
Beta | 0.65 | ||
Volatility % | 62.89 | ||
14-Day RSI | 57.49 | ||
14-Day ATR (â‚©) | 232.181326 | ||
20-Day SMA (â‚©) | 5764 | ||
12-1 Month Momentum % | 11.57 | ||
52-Week Range (â‚©) | 3930 - 6920 | ||
Shares Outstanding (Mil) | 11.41 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pangen Biotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pangen Biotech Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Pangen Biotech Inc Frequently Asked Questions
What is Pangen Biotech Inc(XKRX:222110)'s stock price today?
When is next earnings date of Pangen Biotech Inc(XKRX:222110)?
Does Pangen Biotech Inc(XKRX:222110) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |